Readystate Asset Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$774K Buy
+2,200
New +$784K 0.03% 353
2025
Q2
Sell
-7,000
Closed -$2.18M 622
2025
Q1
$2.18M Buy
7,000
+800
+13% +$236K 0.07% 314
2024
Q4
$1.62M Sell
6,200
-21,100
-77% -$6.26M 0.05% 348
2024
Q3
$8.8M Buy
27,300
+25,500
+1,417% +$8.34M 0.16% 254
2024
Q2
$562K Sell
1,800
-26,900
-94% -$7.9M 0.02% 488
2024
Q1
$8.16M Buy
28,700
+26,900
+1,494% +$7.87M 0.12% 244
2023
Q4
$518K Buy
1,800
+500
+38% +$136K 0.02% 456
2023
Q3
$349K Hold
1,300
0.02% 445
2023
Q2
$289K Buy
+1,300
New +$302K 0.02% 247

Other funds holding AMGN

Readystate Asset Management's AMGN Position: Q2 2025 in Review

Readystate Asset Management sold out of Amgen (AMGN) in Q2 2025, closing a stake of 1,519 shares — an estimated $473K sold.

Readystate Asset Management first reported a position in AMGN in Q3 2024 and held it in 3 quarters. The position peaked at $2.19M in Q3 2024. 2,851 funds tracked by Wall St. Rank hold AMGN as of Q2 2025.

  • Readystate Asset Management reported no remaining Amgen position as of Q2 2025 after selling out during the quarter.
  • Readystate Asset Management sold 1,519 Amgen shares in Q2 2025, an estimated $473K.
  • Readystate Asset Management first reported a position in Amgen in Q3 2024 and held it in 3 quarters.
  • Readystate Asset Management's Amgen position peaked at $2.19M in Q3 2024.
  • 2,851 funds tracked by Wall St. Rank held Amgen as of Q2 2025.

Based on Readystate Asset Management's 13F filing for Q2 2025, filed 7 Aug 2025.